364 related articles for article (PubMed ID: 12724058)
1. Insulin resistance and the sympathetic nervous system.
Egan BM
Curr Hypertens Rep; 2003 Jun; 5(3):247-54. PubMed ID: 12724058
[TBL] [Abstract][Full Text] [Related]
2. Mediators of sympathetic activation in metabolic syndrome obesity.
Straznicky NE; Eikelis N; Lambert EA; Esler MD
Curr Hypertens Rep; 2008 Dec; 10(6):440-7. PubMed ID: 18959829
[TBL] [Abstract][Full Text] [Related]
3. The metabolic syndrome: insulin resistance.
Mikhail N
Curr Hypertens Rep; 2009 Apr; 11(2):156-8. PubMed ID: 19278606
[TBL] [Abstract][Full Text] [Related]
4. Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.
da Silva AA; do Carmo JM; Li X; Wang Z; Mouton AJ; Hall JE
Can J Cardiol; 2020 May; 36(5):671-682. PubMed ID: 32389340
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance and sympathetic overactivity in women.
Kaaja RJ; Pöyhönen-Alho MK
J Hypertens; 2006 Jan; 24(1):131-41. PubMed ID: 16331111
[TBL] [Abstract][Full Text] [Related]
6. Role of sympathetic nervous system and neuropeptides in obesity hypertension.
Hall JE; Brands MW; Hildebrandt DA; Kuo J; Fitzgerald S
Braz J Med Biol Res; 2000 Jun; 33(6):605-18. PubMed ID: 10829088
[TBL] [Abstract][Full Text] [Related]
7. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.
Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME
Circ Res; 2015 Mar; 116(6):991-1006. PubMed ID: 25767285
[TBL] [Abstract][Full Text] [Related]
8. Central sympathetic outflow to skeletal muscle: the major link between non-esterified fatty acids and elevated blood pressure?
Schlaich M
Clin Sci (Lond); 2009 Oct; 118(1):43-5. PubMed ID: 19594440
[TBL] [Abstract][Full Text] [Related]
9. Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome.
Seravalle G; Grassi G
High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):175-9. PubMed ID: 26942609
[TBL] [Abstract][Full Text] [Related]
10. Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease.
Patel SB; Reams GP; Spear RM; Freeman RH; Villarreal D
Curr Hypertens Rep; 2008 Apr; 10(2):131-7. PubMed ID: 18474180
[TBL] [Abstract][Full Text] [Related]
11. Factors that influence the risk of hypertension in obese individuals.
Coatmellec-Taglioni G; Ribière C
Curr Opin Nephrol Hypertens; 2003 May; 12(3):305-8. PubMed ID: 12698070
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance.
Masuo K; Rakugi H; Ogihara T; Esler MD; Lambert GW
Curr Diabetes Rev; 2010 Mar; 6(2):58-67. PubMed ID: 20034369
[TBL] [Abstract][Full Text] [Related]
13. The sympathetic nervous system alterations in human hypertension.
Grassi G; Mark A; Esler M
Circ Res; 2015 Mar; 116(6):976-90. PubMed ID: 25767284
[TBL] [Abstract][Full Text] [Related]
14. Obesity hypertension: role of leptin and sympathetic nervous system.
Hall JE; Hildebrandt DA; Kuo J
Am J Hypertens; 2001 Jun; 14(6 Pt 2):103S-115S. PubMed ID: 11411745
[TBL] [Abstract][Full Text] [Related]
15. Sympathetic and haemodynamic responses to lipids in healthy human ageing.
Florian JP; Pawelczyk JA
Exp Physiol; 2010 Apr; 95(4):486-97. PubMed ID: 20061355
[TBL] [Abstract][Full Text] [Related]
16. [Interactions between obstructive sleep apnea syndrome and insulin resistance].
Carneiro G; Ribeiro Filho FF; Togeiro SM; Tufik S; Zanella MT
Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1035-40. PubMed ID: 18157376
[TBL] [Abstract][Full Text] [Related]
17. Vascular effects of non-esterified fatty acids: implications for the cardiovascular risk factor cluster.
Egan BM; Lu G; Greene EL
Prostaglandins Leukot Essent Fatty Acids; 1999; 60(5-6):411-20. PubMed ID: 10471131
[TBL] [Abstract][Full Text] [Related]
18. The sympathetic nervous system may modulate the metabolic cardiovascular syndrome in essential hypertension.
Kjeldsen SE; Rostrup M; Moan A; Mundal HH; Gjesdal K; Eide IK
J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S32-9. PubMed ID: 1283768
[TBL] [Abstract][Full Text] [Related]
19. Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients.
Seravalle G; Colombo M; Perego P; Giardini V; Volpe M; Dell'Oro R; Mancia G; Grassi G
Hypertension; 2014 Aug; 64(2):431-7. PubMed ID: 24866140
[TBL] [Abstract][Full Text] [Related]
20. [Insulin, nitric oxide and the sympathetic nervous system: from crossroads to metabolic and cardiovascular homeostasis].
Sartori C; Thalmann S; Jayet PY; Duplain H; Vollenweider P; Scherrer U
Rev Med Suisse Romande; 2004 Oct; 124(10):635-8. PubMed ID: 15573509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
